AnalystsEmily BodnarEmily Bodnar's Stock Forecasts
AnalystsEmily Bodnar
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#3701 out of 4237 analysts
Average Return
-3.03%
Win Rate
44%21 out of 48
Risk vs Reward
Poor
Good
Emily Bodnar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dice Therapeutics IncDICE | +86.99% | $16.06 | $30.03 | 2022-07-18 - 2023-06-02 | Buy |
Ventyx Biosciences IncVTYX | +54.62% | $21.99 | $34.00 | 2022-09-01 - 2023-06-02 | Buy |
Olema Pharmaceuticals IncOLMA | +45.76% | $3.89 | $5.67 | 2023-03-10 - 2023-06-02 | Buy |
Gracell Biotechnologies IncGRCL | +45.71% | $2.10 | $3.06 | 2023-02-16 - 2023-06-02 | Buy |
Arcellx IncACLX | +38.22% | $30.38 | $41.99 | 2023-02-13 - 2023-06-02 | Buy |
Emily Bodnar Analyst Color
Get additional color on Emily Bodnar's coverage of popular stocks
Emily Bodnar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | 4 | Buy | $12.00 | +292.16% | Reiterates | 9 days ago |
Purple Biotech LtdPPBT | 3 | Buy | $7.00 | +319.16% | Reiterates | 18 days ago |
Mink Therapeutics IncINKT | 4 | Buy | $10.00 | +446.45% | Maintains | 23 days ago |
Imunon IncIMNN | 2 | Buy | $12.00 | +860.00% | Reiterates | 23 days ago |
Dice Therapeutics IncDICE | 6 | Buy | $60.00 | +99.80% | Reiterates | 23 days ago |
Ventyx Biosciences IncVTYX | 4 | Buy | $54.00 | +58.82% | Reiterates | 23 days ago |
Olema Pharmaceuticals IncOLMA | 4 | Buy | $17.00 | +199.82% | Maintains | 23 days ago |
Arcellx IncACLX | 3 | Buy | $49.00 | +16.69% | Maintains | a month ago |
Novocure LtdNVCR | 3 | Buy | $115.00 | +44.62% | Maintains | a month ago |
Acrivon Therapeutics IncACRV | 2 | Buy | $24.00 | +94.02% | Reiterates | a month ago |
Nkarta IncNKTX | 2 | Buy | $30.00 | +531.58% | Maintains | 3 months ago |
Io Biotech IncIOBT | 2 | Buy | $10.00 | +395.05% | Reiterates | 3 months ago |
Agenus IncAGEN | 1 | Buy | $8.00 | +400.00% | Assumes | 3 months ago |
Briacell Therapeutics CorpBCTX | 2 | Buy | $25.00 | +305.19% | Reiterates | 3 months ago |
Context Therapeutics IncCNTX | 2 | Buy | $4.00 | +212.50% | Reiterates | 4 months ago |
Sqz Biotechnologies CoSQZ | 2 | Hold | N/A | N/A | Downgrades | 6 months ago |
Transcode Therapeutics IncRNAZ | 2 | Buy | $120.00 | +2,937.97% | Maintains | 7 months ago |
Femasys IncFEMY | 2 | Buy | $5.00 | +584.93% | Maintains | 7 months ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.